Evidence map›Paper›PMID 36442457›Full record

ReviewInternational journal of hygiene and environmental health2023

Exposure to flame retardants in European children - Results from the HBM4EU aligned studies.

Veronica van der Schyff, Jiři Kalina, Eva Govarts, Liese Gilles, Greet Schoeters, Argelia Castaño, Marta Esteban-López, Jiři Kohoutek, Petr Kukučka, Adrian Covaci and 21 more

Open access · hybridAbstract readReview
In one paragraph

Review in International journal of hygiene and environmental health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 10 institutions in 11 countries.

Veronica van der SchyffRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
Jiři KalinaRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
Eva GovartsVITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium.
Liese GillesVITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium.
Greet SchoetersVITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium; Department of Biomedical Sciences, University of Antwerp, 2020, Antwerp, Belgium.
Argelia CastañoNational Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Marta Esteban-LópezNational Centre for Environmental Health, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Jiři KohoutekRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
Petr KukučkaRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
Adrian CovaciToxicological Center, University of Antwerp, 2610 Wilrijk, Belgium.
Gudrun KoppenVITO Health, Flemish Institute for Technological Research (VITO), Mol, 2400, Belgium.
Lenka AndrýskováRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
Pavel PilerRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
Jana KlánováRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.
Tina Kold JensenDepartment of Environmental Medicine, Institute of Public Health, University of Southern Denmark, Odense, 5000, Denmark.
Loic RambaudSanté Publique France, French Public Health Agency (ANSP), Saint-Maurice, 94415, France.
Margaux RiouSanté Publique France, French Public Health Agency (ANSP), Saint-Maurice, 94415, France.
Marja LamoreeVrije Universiteit, Amsterdam Institute for Life and Environment, Section Chemistry for Environment & Health, De Boelelaan 1108, 1081 HZ, Amsterdam, Netherlands.
Marike Kolossa-GehringGerman Environment Agency (UBA), 06844 Dessau-Roßlau, Germany.
Nina VogelGerman Environment Agency (UBA), 06844 Dessau-Roßlau, Germany.
Till WeberGerman Environment Agency (UBA), 06844 Dessau-Roßlau, Germany.
Thomas GöenIPASUM - Institute and Outpatient Clinic of Occupational, Social and Environmental Medicine, Henkestrasse 9-11, 91054, Erlangen, Germany.
Catherine GabrielEnvironmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece.
Dimosthenis A SarigiannisEnvironmental Engineering Laboratory, Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece; HERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, 57001, Greece; Environmental Health Engineering, Institute of Advanced Study, Palazzo del Broletto, Piazza Della Vittoria 15, 27100, Pavia, Italy.
Amrit Kaur SakhiDepartment of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Line Småstuen HaugDepartment of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Lubica Palkovicova MurinovaFaculty of Public Health, Slovak Medical University, Bratislava, 833 03, Slovakia.
Lucia FabelovaFaculty of Public Health, Slovak Medical University, Bratislava, 833 03, Slovakia.
Janja Snoj TratnikDepartment of Environmental Sciences, Jožef Stefan Institute, Ljubljana, 1000, Slovenia.
Darja MazejDepartment of Environmental Sciences, Jožef Stefan Institute, Ljubljana, 1000, Slovenia.
Lisa MelymukRECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic. Electronic address: lisa.melymuk@recetox.muni.cz.
University of Southern Denmark · DKMasaryk University · CZFlemish Institute for Technological Research · BEGerman Environment Agency · DEInstituto de Salud Carlos III · ESNorwegian Institute of Public Health · NOSanté Publique France · FRSlovak Medical University · SKUniversity of Antwerp · BEVrije Universiteit Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many legacy and emerging flame retardants (FRs) have adverse human and environmental health effects. This study reports legacy and emerging FRs in children from nine European countries from the HBM4EU aligned studies. Studies from Belgium, Czech Republic, Germany, Denmark, France, Greece, Slovenia, Slovakia, and Norway conducted between 2014 and 2021 provided data on FRs in blood and urine from 2136 children. All samples were collected and analyzed in alignment with the HBM4EU protocols. Ten halogenated FRs were quantified in blood, and four organophosphate flame retardants (OPFR) metabolites quantified in urine. Hexabromocyclododecane (HBCDD) and decabromodiphenyl ethane (DBDPE) were infrequently detected (<16% of samples). BDE-47 was quantified in blood from Greece, France, and Norway, with France (0.36 ng/g lipid) having the highest concentrations. BDE-153 and -209 were detected in <40% of samples. Dechlorane Plus (DP) was quantified in blood from four countries, with notably high median concentrations of 16 ng/g lipid in Slovenian children. OPFR metabolites had a higher detection frequency than other halogenated FRs. Diphenyl phosphate (DPHP) was quantified in 99% of samples across 8 countries at levels ∼5 times higher than other OPFR metabolites (highest median in Slovenia of 2.43 ng/g lipid). FR concentrations were associated with lifestyle factors such as cleaning frequency, employment status of the father of the household, and renovation status of the house, among others. The concentrations of BDE-47 in children from this study were similar to or lower than FRs found in adult matrices in previous studies, suggesting lower recent exposure and effectiveness of PBDE restrictions.

Indexed as

Flame RetardantsAdultChildEuropeHalogenated Diphenyl EthersHumansLipids2,2',4,4'-tetrabromodiphenyl etherFlame RetardantsHalogenated Diphenyl EthersLipidsChildrenEuropeHBM4EUHuman biomonitoringOrganophosphate flame retardantsPolybrominated diphenyl ethers

Identifiers

PMID36442457
PMCPMC9758617
OpenAlexW4310016953

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.